and the related, (GMO) regulatory compliance costs, increasing R & D costs and the need for the expansion of and access to new markets in order for the seed industry to remain competitive have played a vital role in this regard. 3. Patent law is an area that is highly regulated by international treaties, such as the 1994 Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPs) to which both the EU and its Member States are signatories. Any changes to the Biotechnology Directive must therefore stay inside bounds set by the TRIPs Agreement, but also the case-law of the Court of Justice. Bearing in mind the limited amount of case-law the Commission is at this stage not in the position to assess the feasibility and desirability of introducing new prohibitions into the Biotechnology Directive.